Recently, Pfizer has agreed to pay $44 million to settle allegations related to the contamination of its smoking cessation drug Chantix with a carcinogenic compound, nitrosamine. This collective lawsuit against the international pharmaceutical giant Pfizer has once again brought to public attention the contamination scandal that shocked the world several years ago.
Chantix, known in Chinese as 暢沛 / 戒必適, has been a prescription smoking cessation medication relied upon by millions worldwide since its launch in 2006. However, in 2021, Pfizer found during a self-assessment and regulatory review that multiple batches of Chantix contained nitrosamine impurities, N-nitroso-varenicline, that did not meet safety standards. Prolonged exposure to elevated levels of nitrosamine can increase the risk of cancer in humans. Subsequently, in September 2021, Pfizer voluntarily recalled all batches of Chantix in the United States.
The recall triggered a collective lawsuit by American consumers, accusing Pfizer of selling contaminated and defective medication, leading to additional economic losses and health risks for consumers. While Pfizer eventually agreed to contribute $44 million to settle with the plaintiffs, it maintained in legal documents that it does not acknowledge any illegal or negligent behavior, emphasizing that the settlement is only to end the lengthy litigation process.
The settlement funds will be used to compensate consumers who purchased the drug during the specified period. According to the settlement terms, eligible claimants and application conditions are as follows:
Eligibility: Consumers who purchased Chantix in the United States and its territories between September 29, 2015, and September 17, 2021.
Documentation: Claimants must provide relevant retail purchase proof, such as pharmacy prescription records, receipts, or credit card statements.
Key Timeline: Claims must be submitted by September 14, 2026, with the court scheduled to hold a final approval hearing on October 13, 2026. The actual cash compensation amount for each eligible claimant will be distributed post-hearing based on the final total number of applicants and the remaining settlement funds after deducting litigation costs.
New York consumers who purchased Pfizer’s smoking cessation medication during the mentioned period can file a claim for compensation on https://chantixsettlement.com/file-a-claim website.